Assignee
GENESENSE TECHNOLOGIES INC
CA·8 granted patents·5 pending applications·103 citations·filing 1997–2005
Top patents by PatentIndex Score
13 records- 0184US6121000AAntitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Sep 19, 2000·62 cites·11 claims
- 0259US6566514B1Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted May 20, 2003·16 cites·13 claims
- 0358US6593305B1Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Jul 15, 2003·11 cites·13 claims
- 0457US2007032442A1Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cellsGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 0550US6417169B1Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Jul 9, 2002·7 cites·20 claims
- 0649US2008311126A1Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of CancerGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 0747US2003087866A1Suppression of malignancy utilizing ribonucleotide reductase R1GENESENSE TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 0847US2002187954A1Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 0944US2008255065A1Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses ThereofGENESENSE TECHNOLOGIES INC·Filed 2005·Application pending·0 cites
- 1038US7087580B2Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1999·Granted Aug 8, 2006·4 cites·40 claims
- 1136US6610539B1Antisense oligonucleotide sequences as inhibitors of microorganismsGENESENSE TECHNOLOGIES INC·Filed 1998·Granted Aug 26, 2003·3 cites·21 claims
- 1231US6472376B2Suppression of malignancy utilizing ribonucleotide reductase R1GENESENSE TECHNOLOGIES INC·Filed 1998·Granted Oct 29, 2002·0 cites·10 claims
- 1330US7223849B1Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growthGENESENSE TECHNOLOGIES INC·Filed 1997·Granted May 29, 2007·0 cites·52 claims
Join the waitlist — get patent alerts
Get an alert when GENESENSE TECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →